期刊文献+

血浆置换治疗ABO血型不合异体外周血干细胞移植后纯红再生障碍性贫血 被引量:7

Suceessful treatment of ppure red cell aplasia after major ABO incompatible peripheral blood stem cell with plasma exchange
暂未订购
导出
摘要 目的:观察血浆置换治疗ABO 血型不合异体外周血干细胞移植后出现红系再生障碍的疗效。方法:CS3 000 Plus 血浆置换,回输“AB”型健康人血浆及706 代血浆。结果:置换后10 d Hb上升,3 周后上升为94 g/L。结论:血浆置换是治疗ABO 血型不合异体外周血干细胞移植后纯红再障比较好的方法。 Objective:To treat pure red cell aplasia caused by major ABO incompatible allo PBSCT with CS 3000 plus plasma exchange,and observe the treatment results.Methods:CS 3000 plus plasma exchange,and then transfusion human "AB" type plasma.Results:10 days after treatment,Hb began to rise,after three weeks,Hb rise to 94 g/L.Conclusion:Plasma exchange was a better method to treat PRCA complicating ABO incompatible allo PBSCT.
出处 《临床血液学杂志》 CAS 2000年第1期19-20,共2页 Journal of Clinical Hematology
关键词 血浆置换 干细胞移植 纯红 再生障碍性贫血 Blood plasma removing Blood type unsuitable Allo PBSCT
  • 相关文献

参考文献3

  • 1Gmur J P,Burger J, Schallner A, et al. Pure redcell aplasia of long duraeion comneicating major ABO-incomnatible. Bone MarrowTransptantation,1990,75:290~295
  • 2Da W M, Liu Y, Zhong J T,et al. Autologous bone marrow mixde with HLAhaploidentical allogeneic marrow transpeantation for treatment of patients with matignaneblood diseases. Bone Marrow Transplant 1997,19:107~112
  • 3LaiSP,RenHM,HuHT,etal.APCR-SSO,studyofDNApolymorhpisminHLA-DRBgeneinnorthwestChinese(Han)population.JXinMedUniv,1997,9:91-97 收稿1999-01-15 修回1999-09-10

同被引文献21

  • 1张传仓,常平,朱为国,兰和魁,张翠梅,封志纯.血浆置换预防ABO血型不合的儿童骨髓移植中溶血2例[J].中国输血杂志,2005,18(3):221-222. 被引量:1
  • 2郭乃榄,陆道培.ABO血型不含骨髓移植的骨髓处理问题[J].中华器官移植杂志,1989,10(2):84-86. 被引量:6
  • 3赵咏梅,刘林.获得性纯红再障的多致病因素分析[J].重庆医学,2006,35(7):658-659. 被引量:4
  • 4MIELCAREK M,LEISENRING W,TOROK-STORB B,et al.Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts:evidence for a graft-versus-plasma cell effect[J].Blood,2000, 96(3):1 150-1 156.
  • 5BENJAMIN R J,CONNORS J M,MCGURK S,et al.Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia[J].Biol Blood Marrow Transplant,1998,4(3):151-156.
  • 6BAR B M,VAN DLJK B A,SCHATLENBERG A,et al.Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow[J].Bone Marrow Transplant,1995,16(6):793-799.
  • 7Mcarekm,Leisinringw,Torok-storb B,et al.Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts:evidence for graft-versus-plasma cell effect[J].Blood,2000,96(3):1 150.
  • 8Kanda Y,Tanosaki R,Nakai K,et al.Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor[J].Br J Haematol,2002,118:128.
  • 9Goldman J,Liesveld J,Nichols D,et al.ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stemcell transplantation[J].Leuk Res,2003,27:489.
  • 10E Bullorsky,C Shanley,G Stemmelin,et al.Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells Medicina (B Aires)[J].Jan,2002,62(6):575.

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部